A previous study showed that loss of Smad4expression in PDA can lead to the aberrant activation of STAT3, which may contributeto the switch in function of TGFβ from a tumor-suppressive to a tumor-promotingEMT pathway in PDA [20]. The gene discussed is STAT3; the disease is Patent ductus arteriosus.